![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Living in Limbo: Managing Risk, Care, and Clarity with a Precursor Condition
Living in Limbo: Managing Risk, Care, and Clarity with a Precursor Condition
Event Description
Being diagnosed with a blood cancer precursor like MGUS, SMM, CHIP, CCUS, MDS/MPNs, can feel like living in medical limbo. In this session, Dr. Tremblay from Mount Sinai will address key concerns like the risk of progression, treatment decisions, how to partner with your care team, and the role of clinical trials. Whether you’re newly diagnosed or monitoring your condition over time, this webinar will help you better understand your diagnosis and confidently navigate what comes next.
Schedule & Agenda
Mary introduces the agenda and our featured speaker Dr. Douglas Tremblay
Mary introduces the agenda and our featured speaker Dr. Douglas Tremblay
Dr. Douglas Tremblay talks about key concerns like the risk of progression, treatment decisions, how to partner with your care team, and the role of clinical trials
Dr. Douglas Tremblay talks about key concerns like the risk of progression, treatment decisions, how to partner with your care team, and the role of clinical trials
Come with your questions and we will answer them!
Come with your questions and we will answer them!
Speakers & Moderators
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms. Dr. Tremblay specializes in hematologic malignancies including acute myeloid leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.
Join the Conversation
This event is part of the Watch and Wait group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
Get the Latest Blood Cancer Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Together we care.
Together we cure.